Cancer Incidence for Chelsea, Clinton & Midtown Business District, New York (Manhattan) County, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Males and Females | Males | Females | ||||||
---|---|---|---|---|---|---|---|---|---|
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 815.8 | 485.7 | 470.6-501.3 | 432.4 | 518.8 | 496.5-542.1 | 383.4 | 473.3 | 451.6-496.0 |
Oral cavity and pharynx | 23.4 | 14.0 | 11.5-16.9 | 16.4 | 19.2 | 15.2-24.2 | 7.0 | 8.2 | 5.6-11.7 |
Esophagus | 6.0 | 3.6 | 2.4-5.3 | 4.6 | 5.8 | 3.7-9.1 | 1.4 | 1.6 | 0.6-3.8 |
Stomach | 11.6 | 7.1 | 5.4-9.3 | 6.6 | 8.6 | 5.8-12.4 | 5.0 | 5.8 | 3.7-8.9 |
Colorectal | 58.0 | 35.0 | 31.1-39.5 | 34.6 | 43.4 | 37.1-50.8 | 23.4 | 27.7 | 22.8-33.5 |
Colon excluding rectum | 38.6 | 23.4 | 20.1-27.0 | 22.0 | 28.2 | 23.1-34.4 | 16.6 | 19.2 | 15.2-24.1 |
Rectum & rectosigmoid | 19.4 | 11.7 | 9.4-14.4 | 12.6 | 15.2 | 11.6-19.8 | 6.8 | 8.5 | 5.8-12.3 |
Liver / intrahepatic bile duct | 18.4 | 10.7 | 8.6-13.3 | 13.4 | 15.6 | 12.0-20.2 | 5.0 | 6.1 | 3.9-9.3 |
Pancreas | 22.6 | 13.4 | 11.0-16.2 | 11.0 | 13.6 | 10.2-18.1 | 11.6 | 12.9 | 9.8-17.0 |
Larynx | 3.6 | 2.1 | 1.3-3.6 | 2.6 | 2.9 | 1.6-5.5 | 1.0 | 1.3 | 0.4-3.5 |
Lung and bronchus | 80.2 | 47.9 | 43.3-53.0 | 40.2 | 49.6 | 42.8-57.3 | 40.0 | 46.3 | 40.0-53.5 |
Melanoma of the skin | 35.0 | 20.2 | 17.2-23.6 | 21.2 | 24.8 | 20.1-30.3 | 13.8 | 17.2 | 13.2-22.2 |
Female breast | 115.4 | 149.6 | 137.3-162.9 | ||||||
Cervix uteri | 7.6 | 9.4 | 6.6-13.2 | ||||||
Corpus uterus and NOS | 31.6 | 39.6 | 33.5-46.6 | ||||||
Ovary | 11.2 | 14.6 | 10.9-19.3 | ||||||
Prostate | 118.0 | 138.0 | 126.9-150.0 | ||||||
Testis | 7.8 | 7.0 | 4.9-10.2 | ||||||
Urinary bladder (incl. in situ) | 30.2 | 18.5 | 15.6-21.8 | 23.2 | 30.4 | 25.0-36.8 | 7.0 | 8.1 | 5.6-11.6 |
Kidney and renal pelvis | 21.0 | 12.9 | 10.5-15.7 | 14.8 | 17.6 | 13.8-22.5 | 6.2 | 7.9 | 5.3-11.5 |
Brain and other central nervous system | 12.6 | 7.7 | 5.8-10.2 | 9.4 | 11.5 | 8.1-16.0 | 3.2 | 3.7 | 2.1-6.5 |
Thyroid | 33.6 | 18.8 | 16.0-22.1 | 10.0 | 11.3 | 8.3-15.3 | 23.6 | 28.9 | 23.6-35.2 |
Hodgkin lymphoma | 6.4 | 3.1 | 2.1-4.6 | 3.8 | 3.6 | 2.1-6.2 | 2.6 | 2.4 | 1.2-4.6 |
Non-Hodgkin lymphomas | 36.8 | 21.7 | 18.6-25.2 | 22.0 | 26.3 | 21.5-32.0 | 14.8 | 17.3 | 13.4-22.0 |
Myeloma | 10.0 | 5.7 | 4.2-7.7 | 6.2 | 7.6 | 5.1-11.1 | 3.8 | 4.1 | 2.5-6.8 |
Leukemias | 26.0 | 16.7 | 13.8-20.1 | 15.8 | 20.2 | 15.8-25.6 | 10.2 | 13.7 | 9.9-18.6 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYC neighborhoods were defined in terms of Public Use Microdata Areas (PUMAs). PUMAs approximate NYC Community Districts (CDs).
- For more information about PUMAs, please refer to http://www1.nyc.gov/site/planning/data-maps/nyc-population/geographic-reference.page.